Paper40831663
Administration of Cilostazol Prior to Intravenous Alteplase for Acute Branch Atheromatous Disease: A Report of Three Cases.
Tanaka E and 4 others. Case Rep Neurol Med, 2025. Cited by 0 papers, by iCite.
Cite this record
ConductScience Library. Administration of Cilostazol Prior to Intravenous Alteplase for Acute Branch Atheromatous Disease: A Report of Three Cases. Papers, record 40831663. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/40831663
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Administration of Cilostazol Prior to Intravenous Alteplase for Acute Branch Atheromatous Disease: A Report of Three Cases.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References15
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 23246192 | Treatment outcomes of tissue plasminogen activator infusion for branch atheromatous disease. | J Stroke Cerebrovasc Dis | 2013 | https://conductscience.org/library/papers/23246192 | PubMed |
| 2 | 32733357 | Efficacy and Safety of Intravenous Thrombolysis on Acute Branch Atheromatous Disease: A Retrospective Case-Control Study. | Front Neurol | 2020 | https://conductscience.org/library/papers/32733357 | PubMed |
| 3 | 22748820 | Early administration of aspirin in patients treated with alteplase for acute ischaemic stroke: a randomised controlled trial. | Lancet | 2012 | https://conductscience.org/library/papers/22748820 | PubMed |
| 4 | 2671793 | Intracranial branch atheromatous disease: a neglected, understudied, and underused concept. | Neurology | 1989 | https://conductscience.org/library/papers/2671793 | PubMed |
| 5 | 24820203 | Benefit of cilostazol in patients with high risk of bleeding: subanalysis of cilostazol stroke prevention study 2. | Cerebrovasc Dis | 2014 | https://conductscience.org/library/papers/24820203 | PubMed |
| 6 | 33882341 | Safety and efficacy of antiplatelet use before intravenous thrombolysis for acute Ischemic stroke. | J Neurol Sci | 2021 | https://conductscience.org/library/papers/33882341 | PubMed |
| 7 | 22632908 | The benefits and harms of intravenous thrombolysis with recombinant tissue plasminogen activator within 6 h of acute ischaemic stroke (the third international stroke trial [IST-3]): a randomised controlled trial. | Lancet | 2012 | https://conductscience.org/library/papers/22632908 | PubMed |
| 8 | 36757755 | Effect of Argatroban Plus Intravenous Alteplase vs Intravenous Alteplase Alone on Neurologic Function in Patients With Acute Ischemic Stroke: The ARAIS Randomized Clinical Trial. | JAMA | 2023 | https://conductscience.org/library/papers/36757755 | PubMed |
| 9 | 27728903 | Ultra-Early Combination Antiplatelet Therapy with Cilostazol for the Prevention of Branch Atheromatous Disease: A Multicenter Prospective Study. | Cerebrovasc Dis Extra | 2016 | https://conductscience.org/library/papers/27728903 | PubMed |
| 10 | 7477192 | Tissue plasminogen activator for acute ischemic stroke. | N Engl J Med | 1995 | https://conductscience.org/library/papers/7477192 | PubMed |
| 11 | 27452127 | Intravenous tissue plasminogen activator in acute branch atheromatous disease: Does it prevent early neurological deterioration? | J Clin Neurosci | 2016 | https://conductscience.org/library/papers/27452127 | PubMed |
| 12 | 21402390 | Characteristics of intracranial branch atheromatous disease and its association with progressive motor deficits. | J Neurol Sci | 2011 | https://conductscience.org/library/papers/21402390 | PubMed |
| 13 | 20833591 | Cilostazol for prevention of secondary stroke (CSPS 2): an aspirin-controlled, double-blind, randomised non-inferiority trial. | Lancet Neurol | 2010 | https://conductscience.org/library/papers/20833591 | PubMed |
| 14 | 20056933 | Safety of intravenous thrombolysis for acute ischemic stroke in patients receiving antiplatelet therapy at stroke onset. | Stroke | 2010 | https://conductscience.org/library/papers/20056933 | PubMed |
| 15 | 32686168 | Prior Dual Antiplatelet Therapy and Thrombolysis in Acute Stroke. | Ann Neurol | 2020 | https://conductscience.org/library/papers/32686168 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Cited by
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/40831663
GET https://conductscience.org/api/papers/v1/40831663/authors